424
A MULTICENTER, RANDOMIZED OPEN-LABEL TRIAL COMPARING 1-DAY CESSATION OF DIRECT ORAL ANTICOAGULANTS BEFORE AND AFTER COLORECTAL POLYPECTOMY -MADOWAZU TRIAL-
Date
May 19, 2024
Tracks
Related Products
STANDARD VS. COMPUTER-AIDED DETECTION ASSISTED COLONOSCOPY FOR DETECTION OF COLORECTAL NEOPLASIA: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL
Background: With the rapid advance of artificial intelligence (AI) technology, AI approved as a medical device is being introduced into daily clinical practice. Several studies reported the efficacy of Computer-Aided Detection (CADe) in colonoscopy for adenoma detection…
EPINEPHRINE-ADDED SOLUTION SIGNIFICANTLY REDUCED PROCEDURAL TIME DURING GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) – RESULTS FROM AN INTERNATIONAL MULTI-CENTER RANDOMIZED CONTROLLED TRIAL
Endoscopic submucosal dissection (ESD) has become a standard therapy for early gastric cancer. The type of submucosal injection solution used during gastric ESD varies among endoscopists…
RISK FACTORS FOR THE PERITONITIS ASSOCIATED WITH ENDOSCOPIC ULTRASOUND-GUIDED HEPATICOGASTROSTOMY
INTRODUCTION: Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) has been performed as an alternative drainage to endoscopic retrograde cholangiopancreatography (ERCP) for advanced cancer. However, Peritonitis, which is less likely to occur with ERCP, is observed in 3.6-9.4% after EUS-HGS…
A RANDOMIZED, NON-COMPARATIVE PHASE II TRIAL TO EXPLORE THE OPTIMAL ENDOSCOPIC ULTRASOUND-GUIDED TISSUE ACQUISITION METHOD FOR OBTAINING SPECIMEN FOR COMPREHENSIVE GENOMIC PROFILING IN PATIENTS WITH PANCREATIC CANCER
INTRODUCTION: In recent years, matched therapy based on comprehensive genomic profiling (CGP) has extended the prognosis of pancreatic cancer patients. Foundation One CDx® (F1CDx) is a representative test of commercially available CGP (CACGP)…